No Record Found
Sector
PharmaceuticalsOpen
₹561.25Prev. Close
₹562.1Turnover(Lac.)
₹25.71Day's High
₹567.9Day's Low
₹54552 Week's High
₹95052 Week's Low
₹500Book Value
₹113.1Face Value
₹10Mkt Cap (₹ Cr.)
701.78P/E
32.05EPS
17.06Divi. Yield
0No Record Found
Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
---|---|---|---|---|
Equity Capital | 12.84 | 12.84 | 12.51 | 12.01 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 132.36 | 109.26 | 74.69 | 49.57 |
Net Worth | 145.2 | 122.1 | 87.2 | 61.58 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 49.07 | 58.42 | 27.26 | 19.85 |
yoy growth (%) | -16 | 114.31 | 37.27 | 27.95 |
Raw materials | -22.01 | -35.59 | -14.91 | -10.03 |
As % of sales | 44.86 | 60.92 | 54.7 | 50.53 |
Employee costs | -3.84 | -3.26 | -2.36 | -1.86 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 12.94 | 12.74 | 6.47 | 3.94 |
Depreciation | -2.72 | -2.24 | -0.59 | -0.54 |
Tax paid | -3.19 | -3.11 | -1.78 | -1.3 |
Working capital | 4.53 | 0.28 | 7.9 | 2.61 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -16 | 114.31 | 37.27 | 27.95 |
Op profit growth | 24.67 | 110.98 | 27.57 | 110.71 |
EBIT growth | 1.02 | 95.9 | 64.91 | 136.73 |
Net profit growth | 1.34 | 105.33 | 77.66 | 141.17 |
Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2021 | Mar-2020 | Mar-2019 |
---|---|---|---|---|---|
Gross Sales | 108.6 | 125.9 | 49.08 | 64.02 | 35.31 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 108.6 | 125.9 | 49.08 | 64.02 | 35.31 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 3.73 | 3.07 | 2.09 | 3.91 | 1.17 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,616.25 | 77.85 | 3,87,792.51 | 753.53 | 0.99 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,026.55 | 68.48 | 1,59,985.97 | 557 | 0.5 | 2,357 | 561.08 |
Cipla Ltd CIPLA | 1,573.8 | 24.61 | 1,27,124.34 | 1,303.13 | 1.02 | 4,501.66 | 397.38 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,566.3 | 60.71 | 1,20,694.38 | 551 | 0.17 | 2,567 | 224.34 |
Dr Reddys Laboratories Ltd DRREDDY | 1,316.4 | 15.94 | 1,09,867.7 | 2,961.2 | 0.61 | 7,788.7 | 345.75 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman / Executive Director / Managing Director
Chandubhai Kothia
Executive Director / Whole Time Director / CFO
Parth Chandulal Kothia
E D & Wholetime Director
Gunjan Chandulal Kothia
Independent Non Exe. Director
Priyam Surendra Shah
Independent Non Exe. Director
Maulikkumar Sudani
Independent Non Exe. Director
Parul Sahani
Independent Non Exe. Director
Shruti Rajesh Sohane
Company Sec. & Compli. Officer
Aditya Patel
Plot No 6011,
GIDC,
Gujarat - 393002
Tel: 91-2646-227777
Website: http://www.ganeshremedies.com
Email: investors@ganeshremedies.com
Office No 56-2,
Pinnacle Busine.Park, Mahakali Caves Road,
Mumbai - 400093
Tel: 91-22-62638200
Website: www.bigshareonline.com
Email: investor@bigshareonline.com
Summary
Shree Ganesh Remedies Limited was originally incorporated as a Private Limited Company with the name Shree Ganesh Remedies Private Limited at Ahmedabad, Gujarat on April 27, 1995. Subsequently the Com...
Read More
Reports by Shree Ganesh Remedies Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.